Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor

J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):57-65. doi: 10.1097/00002371-199507000-00008.

Authors

L Wong¹, C W Taylor, E Radwanski, E M Hersh, S E Salmon

Affiliation

¹ Arizona Cancer Center, Tucson 85724, USA.

PMID: 8535572
DOI: 10.1097/00002371-199507000-00008

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase I
Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Drug Administration Schedule
Female
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage*
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacokinetics
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms / therapy*
Recombinant Proteins / administration & dosage
Recombinant Proteins / adverse effects
Recombinant Proteins / pharmacokinetics

Substances

Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor